Full-Time

IT Governance Lead

IT Governance

Posted on 8/19/2025

Inizio

Inizio

5,001-10,000 employees

Guides clinical development and commercialization

No salary listed

London, UK + 1 more

More locations: Manchester, UK

Remote

Flexible working arrangements include onsite, remote, or hybrid.

Category
IT & Security (1)
Required Skills
Oracle
Requirements
  • 8+ years of experience in IT risk and compliance, focusing on ITGCs, SOX, and IT Controls
  • Relevant certifications such as CGEIT or CISA, are highly desirable
  • Strong analytical, organizational, and problem-solving capabilities
  • Excellent communication skills, capable of articulating complex IT issues to non-technical audiences
  • Ability to guide IT and business stakeholders in the delivery of a compliant environment
  • Confidence to challenge the status quo and influence senior stakeholders
  • Ability to work independently and collaboratively in a dynamic, fast-paced environment
  • Experience in or with publicly traded companies, Big Four audit firms, or similar is advantageous
  • Proficient in the management and documentation of ITGCs and IT application controls in environments such as SaaS applications, cloud infrastructures, in-house developed applications, and on-premises infrastructures
  • Experience with Enterprise systems (e.g., Workday, Oracle, Maconomy, Certinia) and other critical platforms
  • Knowledge of industry standards like COBIT and their application in IT compliance
Responsibilities
  • Lead and manage compliance lifecycle components, including risk assessment and scoping, evaluation and remediation of deficiencies identified through testing, and planning remediation activities
  • Lead the evaluation and design of IT controls for new applications to ensure compliance
  • Influence the process and control owners to establish effective enterprise-level controls
  • Direct Internal and External Audit teams to ensure cohesive testing strategies
  • Drive improvements to the ITGC framework
  • Ensure the control environment is understood, remains robust, and within risk appetite
  • Creation and maintenance of policies and procedures, ensuring documentation is accurate and reflects current processes
  • Manage user access reviews across key applications
  • Own the identification, collection, and review of SOC1 reports for third-party dependencies impacting internal controls over financial reporting (ICFR)
  • Identify risks and update appropriate logs
  • Participation in continuous improvement initiatives for the Group's control environment and future-proofing activities
  • Mentoring more junior members of the team
Desired Qualifications
  • Experience in or with publicly traded companies, Big Four audit firms, or similar is advantageous

Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Colin Stanley's CCO appointment on February 6, 2025, drives commercialization growth with 25 years' experience.
  • Patrick Giordani as SVP AI Solutions Architect bolsters AI innovation in medical affairs communications.
  • Nazaré unites 150 experts to enhance employee performance via immersive learning experiences.

What critics are saying

  • Intelligent Automation Congress on March 3-4, 2026, erodes edge with superior AI event automation.
  • Nazaré launch cannibalizes Intelligent Congress budgets, diverting funds to internal learning.
  • Patrick Giordani's AI fails by end-2026, causing client exodus to IA Congress AI networks.

What makes Inizio unique

  • Intelligent Congress integrates strategy, design, delivery, and measurement across congress lifecycles.
  • Inizio supports 175 congresses yearly for 100% of top 20 pharma companies across 50 countries.
  • Four-step framework captures real-time insights from over 25,500 attendees and 1,000 HCP engagements.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Professional Development Budget

Hybrid Work Options

Company News

PR Newswire
Feb 6th, 2025
Inizio Accelerates Growth With A Trio Of Strategic Leadership Appointments

LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization

Bio-IT World
Oct 20th, 2024
Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

Inizio Medical, the leading provider of Medical Affairs and communications solutions, today announced the appointment of Patrick Giordani as Senior Vice President, AI Solutions Architect.

Bio-IT World
Oct 14th, 2024
Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs

Bio-IT World Inc is immensely proud that Matt has chosen to join Inizio Medical and contribute to its mission of providing exceptional medical communications and specialized solutions.

PR Newswire
Oct 18th, 2023
Inizio Engage Launches New Global Powerhouse Learning Brand, Nazaré

FORT WASHINGTON, Pa., Oct. 18, 2023 /PRNewswire/ -- Inizio Engage has announced the launch of Nazaré, a new learning and capability brand. Nazaré brings together 150+ experts in learning, life sciences, creativity, technology, and behavioral science. Nazaré is set to transform workplace learning in order to help companies maintain their leadership in evolving competitive landscapes by unlocking the potential of their people.The new global learning and capability brand will be part of the Experience Design (XD) specialist area within Inizio Engage. This means Nazaré will draw on the rest of Inizio Engage XD's in-house creative and executional capabilities in live events, environments, film, digital, and immersive technologies, as well as considering learning experience design more holistically alongside employee engagement.Nazaré brings together Axiom, Cormis, Logicearth Learning Services and Ashfield Excellence Academy under one brand to support global organizations with a range of learning and capability programs, with an unparalleled level of expertise in end-to-end life sciences learning support for pharmaceutical and biotech companies across the product lifecycle. Nazaré will focus on designing and delivering world-class learning experiences that inspire an immediate and lasting change in performance.Nazaré harnesses science, creativity, and technology to challenge how the Learning & Development industry creates impact for businesses

PR Newswire
Sep 14th, 2023
Innovative Collaboration: Buzzreach And Oncoshot Spearhead Clinical Trial Advancements In Japan

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specialises in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform.Mr Taketeru Inokawa (left) and Dr Huren Sivaraj (right) during the MOU signing ceremony in Singapore.The collaboration will extend to Oncoshot's strategic contract research organisation and pharmaceutical partners. Together, they will focus on recruiting participants for upcoming studies scheduled to begin in Q1 2024."This collaboration marks a significant step in Oncoshot's vision of creating a cancer cohort discovery platform and upcoming national-level clinical trials ecosystems and hospitals globally," said Oncoshot CEO Dr Huren Sivaraj.Central to this partnership is the cost-free infrastructure designed to facilitate the real-time exchange of aggregated insights. This ground-breaking initiative is set to synergise their complementary strengths to enhance various clinical trial aspects throughout Japan, including feasibility assessments, participant screening, and enrolment. Japan is currently ranked as the third-largest pharmaceutical market worldwide

INACTIVE